1-151067437-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_006818.4(MLLT11):c.213C>T(p.Thr71Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00474 in 1,614,138 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0032 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0049 ( 29 hom. )
Consequence
MLLT11
NM_006818.4 synonymous
NM_006818.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.74
Genes affected
MLLT11 (HGNC:16997): (MLLT11 transcription factor 7 cofactor) The gene variously symbolized ALL1, HRX, or MLL located on 11q23 has been demonstrated to be fused with a number of translocation partners in cases of leukemia. t(1;11)(q21;q23) translocations that fused the MLL gene to a gene on chromosomal band 1q21 in 2 infants with acute myelomonocytic leukemia have been demonstrated. The N-terminal portion of the MLL gene is critical for leukemogenesis in translocations involving band 11q23. This gene encodes 90 amino acids. It was found to be highly expressed in the thymus but not in peripheral lymphoid tissues. In contrast to its restricted distribution in normal hematopoietic tissue, this gene was expressed in all leukemic cell lines tested. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.33).
BP6
Variant 1-151067437-C-T is Benign according to our data. Variant chr1-151067437-C-T is described in ClinVar as [Benign]. Clinvar id is 708650.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.74 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 2 AR gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00324 AC: 493AN: 152134Hom.: 2 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
493
AN:
152134
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00394 AC: 990AN: 251470 AF XY: 0.00443 show subpopulations
GnomAD2 exomes
AF:
AC:
990
AN:
251470
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00489 AC: 7152AN: 1461886Hom.: 29 Cov.: 31 AF XY: 0.00500 AC XY: 3636AN XY: 727244 show subpopulations
GnomAD4 exome
AF:
AC:
7152
AN:
1461886
Hom.:
Cov.:
31
AF XY:
AC XY:
3636
AN XY:
727244
Gnomad4 AFR exome
AF:
AC:
23
AN:
33480
Gnomad4 AMR exome
AF:
AC:
86
AN:
44724
Gnomad4 ASJ exome
AF:
AC:
101
AN:
26136
Gnomad4 EAS exome
AF:
AC:
1
AN:
39700
Gnomad4 SAS exome
AF:
AC:
650
AN:
86258
Gnomad4 FIN exome
AF:
AC:
27
AN:
53418
Gnomad4 NFE exome
AF:
AC:
5926
AN:
1112010
Gnomad4 Remaining exome
AF:
AC:
277
AN:
60396
Heterozygous variant carriers
0
414
828
1243
1657
2071
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
208
416
624
832
1040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.00324 AC: 494AN: 152252Hom.: 2 Cov.: 32 AF XY: 0.00304 AC XY: 226AN XY: 74452 show subpopulations
GnomAD4 genome
AF:
AC:
494
AN:
152252
Hom.:
Cov.:
32
AF XY:
AC XY:
226
AN XY:
74452
Gnomad4 AFR
AF:
AC:
0.000770564
AN:
0.000770564
Gnomad4 AMR
AF:
AC:
0.0036654
AN:
0.0036654
Gnomad4 ASJ
AF:
AC:
0.00518433
AN:
0.00518433
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0.008285
AN:
0.008285
Gnomad4 FIN
AF:
AC:
0.000377003
AN:
0.000377003
Gnomad4 NFE
AF:
AC:
0.0048949
AN:
0.0048949
Gnomad4 OTH
AF:
AC:
0.00425331
AN:
0.00425331
Heterozygous variant carriers
0
27
54
82
109
136
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jul 04, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=97/3
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at